Improving Opioid Safety in Veterans Using Collaborative Care and Decision Support
Status: | Recruiting |
---|---|
Conditions: | Chronic Pain, Chronic Pain |
Therapuetic Areas: | Musculoskeletal |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/21/2016 |
Start Date: | November 2014 |
End Date: | January 2017 |
Contact: | Amelia Lipscomb |
Email: | amelia.lipscomb@va.gov |
Phone: | 415 221 4810 |
The investigators propose to develop a novel intervention that targets the system
(Collaborative Care), PCP (computerized decision support for opioid therapy) and veteran
(CM-delivered MI) to reduce problematic prescription opioid use and encourage non-opioid
pain management alternatives.
(Collaborative Care), PCP (computerized decision support for opioid therapy) and veteran
(CM-delivered MI) to reduce problematic prescription opioid use and encourage non-opioid
pain management alternatives.
The investigators will develop and test the acceptability, feasibility, and preliminary
efficacy of a Collaborative Care intervention in which one of two Care Managers delivering
both interventions will assist primary care providers (PCPs) by using Motivational
Interviewing to communicate computer-based ATHENA-OT (opioid therapy) decision support
guidelines to veterans with chronic pain. Specifically, after honing the intervention, the
investigators will conduct a pilot randomized controlled trial of Collaborative
Care/Motivational Interviewing in 100 veterans (ages 18 and older) with chronic pain in
primary care who are prescribed opioid pain medications and exhibit at least one "high-risk"
opioid use behavior (e.g. obtaining early opioid refills, etc.). Using ATHENA-OT decision
support, PCPs will make guideline-concordant recommendations to all enrolled study patients
and initiate a Pain Care Plan. Veterans randomized to Collaborative Care, will have one MI
session with their assigned study Care Manager followed by 3 Care Manager-delivered
telephone MI/monitoring sessions; patients randomized to the Attention Control arm will have
one brief session with their assigned Care Manager, followed by 3 Care Manager-delivered
neutral telephone sessions
efficacy of a Collaborative Care intervention in which one of two Care Managers delivering
both interventions will assist primary care providers (PCPs) by using Motivational
Interviewing to communicate computer-based ATHENA-OT (opioid therapy) decision support
guidelines to veterans with chronic pain. Specifically, after honing the intervention, the
investigators will conduct a pilot randomized controlled trial of Collaborative
Care/Motivational Interviewing in 100 veterans (ages 18 and older) with chronic pain in
primary care who are prescribed opioid pain medications and exhibit at least one "high-risk"
opioid use behavior (e.g. obtaining early opioid refills, etc.). Using ATHENA-OT decision
support, PCPs will make guideline-concordant recommendations to all enrolled study patients
and initiate a Pain Care Plan. Veterans randomized to Collaborative Care, will have one MI
session with their assigned study Care Manager followed by 3 Care Manager-delivered
telephone MI/monitoring sessions; patients randomized to the Attention Control arm will have
one brief session with their assigned Care Manager, followed by 3 Care Manager-delivered
neutral telephone sessions
Inclusion Criteria:
- Current Male or Female patient at San Francisco VA Medical Center or affiliated VA
clinics
- Must be older than 18 years
- Chronic musculoskeletal pain of at least 6 months duration and
- Prescribed one or more opioid pain medication for more than three months and
- Evidence of being a high-risk opioid user as determined by PI, electronic medical
record, and study measures
Exclusion Criteria:
- Non-English speakers
- Plans to relocate within 6 months; not able to come to San Francisco VA Medical
Center for three in-person visits
- Cancer or other terminal illness involving palliative care with opioid medications
- Serious or untreated mental illness
We found this trial at
1
site
San Francisco, California 94121
Principal Investigator: Karen Seal, MD, MPH
Phone: 415-221-4810
Click here to add this to my saved trials